| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/26/2000 | CN1242237A Dietetic food composition and dietetic method using such composition |
| 01/26/2000 | CN1242216A Traditional Chinese medicine for treating asthma |
| 01/26/2000 | CN1242205A Pharmaceutical composition for treating bed sore and ulcerous wound surface |
| 01/26/2000 | CN1242194A Calcium ion concentration liquid and process for producing same |
| 01/26/2000 | CN1242193A Vaginal effervescent-tablets contg. azithromycin |
| 01/26/2000 | CN1242192A Pharmaceutical composition contg. amino-acid adduct |
| 01/26/2000 | CN1242168A Stable type folic acid nutritive product, and prepn. method therefor |
| 01/26/2000 | CN1048730C Zinc pipemidic, process for synthesizing same, and ointment contg. same |
| 01/26/2000 | CN1048729C Novel process for prepn. of anti-ulcer agent |
| 01/26/2000 | CN1048728C 3-substituted 3H,-2,3-benzodiazepine derivatives, their prepn. and use as medicine |
| 01/26/2000 | CN1048727C Process for prepn. of 2-(1-azabicyclo (2,2,2) oct-3-yl)-2,4,5,6-tetrahydro-1H-benz |
| 01/26/2000 | CN1048726C Substituted 4-phenyl thiazole derivant, prepn. and medicine compositions thereof |
| 01/26/2000 | CN1048725C Nicotinic acid derivatives and herbicide |
| 01/26/2000 | CN1048723C Method for preparing benzopyran derivative |
| 01/26/2000 | CN1048722C (S) (+)-2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbonylmethyl]-benzoic acid pharmaceutical compositions contg. same, and process for prepn. |
| 01/26/2000 | CN1048720C New O-arylmethyl-N-(thio) acylhydroxylamines, prepn. method and pharmaceutical compositions thereof |
| 01/26/2000 | CN1048719C Novel 7-(substituted)-8-(substituted)-9-(substituted amino)-6-demethyl-6-deoxytetracyclines, prepn. method, their compositions and use thereof |
| 01/26/2000 | CN1048718C Phenylethyl and phenylpropylamines compounds, prepn. method, pharmaceutical agent and use thereof |
| 01/26/2000 | CN1048714C Elemene-metal complex and use as anticancer drugs |
| 01/26/2000 | CN1048639C Capsule for addition-eliminating and body strengthening function |
| 01/26/2000 | CN1048628C Prepn. of cyclopropyloxacini injection |
| 01/26/2000 | CN1048627C Medicinal aerosol prepn. |
| 01/25/2000 | US6018080 Atovaquone pharmaceutical compositions |
| 01/25/2000 | US6018062 17-difluoromethylene-estratrienes |
| 01/25/2000 | US6018058 1,4 dihydrodioxins and related compounds as DNA cleaving reagents |
| 01/25/2000 | US6018054 Intermediate compounds for preparing novel quinolone and naphthyridone derivatives which are substituted in the 7-position by a partially hydrogenated isoindolinyl ring, use as antibacterial agents and as feed additives |
| 01/25/2000 | US6018053 By carrying out resolution by separating, concentrating or depleting one of the two enantiomeric forms by forming a salt from the racemic compound of given formula and a chiral nonracemic amino compound |
| 01/25/2000 | US6018046 Pyridocarbazole derivatives having cGMP-PDE inhibitory activity |
| 01/25/2000 | US6018042 An oligonucleotide derivative capable of modulating the biosynthesis of human s-adenosylmethionine decarboxylase enzyme; antiproliferative/antitumor/antimetastasis agents |
| 01/25/2000 | US6018025 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd528 as a target |
| 01/25/2000 | US6018019 Immunogenic synthetic peptides which are useful alone or in conjugates in vaccines against hemophilus influenza infection |
| 01/25/2000 | US6017966 Stabilized pharmaceutical compositions containing dobutamine |
| 01/25/2000 | US6017965 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 01/25/2000 | US6017964 Administering to a male patient droloxifene or it's derivatives know as an antiestrogenic agent |
| 01/25/2000 | US6017963 Formulation for intranasal administration |
| 01/25/2000 | US6017961 Ketamine and n-butyl-p-aminobezoate in PLO |
| 01/25/2000 | US6017960 Discoloring or bleaching the skin |
| 01/25/2000 | US6017958 A therapeutic treatment using a methyl alkyloxy- or thio-phenyl benzoate, as potent, selective and non-toxic anti-tumor agents for treating cancer |
| 01/25/2000 | US6017957 Partial agonists of the strychnine insensitive glycine modulatory site of the N-methyl-D-aspartate receptor complex as neuropsychopharmacological agents |
| 01/25/2000 | US6017956 N,N-disubstituted amic acid derivatives |
| 01/25/2000 | US6017954 Angiogenesis inhibitors for treating and preventing angiogenesis-dependent tumors, especially kaposi's sarcoma, breast cancer, colon cancer |
| 01/25/2000 | US6017953 Treating ocular hypotension, hypertension, hemorrhage, myocardial ischemia, angina pectoris, coronary contraction, cerebrovascular contraction after subarachnoidal hemorrhage, and asthma |
| 01/25/2000 | US6017952 Endothelin receptor antagonists |
| 01/25/2000 | US6017950 Methods for controlling gram negative bacteria in mammals |
| 01/25/2000 | US6017949 Controlling the fertility in a female mammal, terminating a pregnancy, controlling pathological conditions and disorders of the female reproductive system |
| 01/25/2000 | US6017948 A pharmaceutically-acceptable anticancer drug paclitaxel in non-aqueous solvent comprising n-methyl pyrrolidone, excluding dimethylacetamide or dimethyl sulfoxide |
| 01/25/2000 | US6017946 Serotonin containing formulation for oral administration and method of use |
| 01/25/2000 | US6017945 Useful in the treatment of restenosis, renal failure and pulmonary hypertension |
| 01/25/2000 | US6017942 A peritoneal dialysis solution comprising a therapeutically effective amount of l-carnosine |
| 01/25/2000 | US6017941 Method of combatting infectious diseases using dicationic bis-benzimidazoles |
| 01/25/2000 | US6017940 Administering the active drug for bone growth replacement, undesirable level of bone resorption, treating fractures, and in treating cartilage disorders |
| 01/25/2000 | US6017939 Treating cardiac, circulatory and vascular diseases, especially of hypertension and cardiac insufficiency |
| 01/25/2000 | US6017938 Treating patient's skin with tazarotene for about thirty seconds |
| 01/25/2000 | US6017937 Pyridine derivative, anti-ulcer drug, and antibacterial drug |
| 01/25/2000 | US6017936 Method for producing particles of pyrithione salts and particles so produced |
| 01/25/2000 | US6017932 Pharmaceutical compositions containing at least one NSAID having increased bioavailability |
| 01/25/2000 | US6017930 Methods of treating or preventing interstitial cystitis |
| 01/25/2000 | US6017929 Cholinesterase activator |
| 01/25/2000 | US6017928 Retroviral protease inhibiting compounds |
| 01/25/2000 | US6017927 Quinuclidine derivatives and medicinal composition thereof |
| 01/25/2000 | US6017926 Integrin receptor antagonists |
| 01/25/2000 | US6017923 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 01/25/2000 | US6017922 Thermally stable trimetrexates and processes for producing the same |
| 01/25/2000 | US6017921 Crystalline trimetrexate salts and the process for making the same |
| 01/25/2000 | US6017920 Antifungal composition for external use being retentive in stratum corneum |
| 01/25/2000 | US6017916 Nonpeptide endothelin antagonists I |
| 01/25/2000 | US6017915 Heterocyclic compounds |
| 01/25/2000 | US6017912 Topical fluoroquinolone antibiotics in an alcohol and acetone vehicle |
| 01/25/2000 | US6017910 PCP receptor ligands and the use thereof |
| 01/25/2000 | US6017909 Salts of azelastine having improved solubility effective at treating psoriasis and providing a cytoprotective effect |
| 01/25/2000 | US6017908 3-EPI vitamin D2 compounds and uses thereof |
| 01/25/2000 | US6017907 Structural analogues of vitamin D |
| 01/25/2000 | US6017906 Polyamine conjugates for treatment of infection |
| 01/25/2000 | US6017904 Steroid sulphatase inhibitors |
| 01/25/2000 | US6017903 Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
| 01/25/2000 | US6017900 Topical composition containing hyaluronic acid and nsaids |
| 01/25/2000 | US6017899 Non-reducing saccharide-forming enzyme, its preparation and uses |
| 01/25/2000 | US6017898 Inhibition of tumor growth by antisense oligonucleotides for IL-8 and IL-8 receptor |
| 01/25/2000 | US6017893 Use of isoflavones to prevent hair loss and preserve the integrity of existing hair |
| 01/25/2000 | US6017892 Method for accelerating marrow cell proliferation |
| 01/25/2000 | US6017889 Metalloproteinase inhibitors |
| 01/25/2000 | US6017871 Protease-containing cleaning compositions |
| 01/25/2000 | US6017768 For screening agonists or antagonists of alpha adrenergic receptors, dopamine receptors, sigma opiate receptors, potassium ion channels, carbonic anhydrase inhibitors; for treatment of glaucoma |
| 01/25/2000 | US6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/25/2000 | US6017728 ribH |
| 01/25/2000 | US6017691 4'-primary aminopsoralen and platelet compositions |
| 01/25/2000 | US6017562 Comprising reacting pyrithione or a water-soluble salt of pyrithione and a water-soluble polyvalent metal salt in the presence of a dispersant at 20 degrees c to 60 degrees c to produce non-spherical and/or non-platelet particles |
| 01/25/2000 | US6017560 Process for producing stabilized pharmaceutical composition |
| 01/25/2000 | US6017557 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof |
| 01/25/2000 | US6017549 Non-irritating cosmetic and pharmaceutical compositions |
| 01/25/2000 | US6017526 Germanium yeast human diet nutritional supplement |
| 01/25/2000 | US6017521 Topically applying a composition comprising water and a water-swellable, water-insoluble, crosslinked, ph buffering, bioadhesive, carboxy-containing addition polymer to acidify; microbiocides; deodorizing |
| 01/25/2000 | US6017520 Penetration enhancement of topically applied therapeutic formulations |
| 01/25/2000 | CA2205546C Oral compositions containing ondansetron |
| 01/25/2000 | CA2184005C Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 01/25/2000 | CA2163904C Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
| 01/25/2000 | CA2117466C Application of 2-amino 6-trifluoromethoxy benzothiazole for obtaining a drug useful in the treatment of motor neuron diseases |
| 01/25/2000 | CA2103351C Method of treatment using steroid mouthwash |
| 01/25/2000 | CA2091994C Complexes of nitric oxide with polyamines |
| 01/25/2000 | CA2086433C Indano pyrrolidine carbamates |